0

Connected Drug Delivery Devices Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21225

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

May 2021

Total pages

214

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

NOWADAYS, PATIENTS AND HEALTHCARE PROVIDERS ARE FOCUSING MORE ON HOME-BASED CARE. MANY PATIENTS ARE OPTING FOR HOME-BASED CARE OWING TO SEVERAL BENEFITS LIKE FEW HOSPITAL VISITING, MONEY-SAVING, TIME-SAVING, AND PERMITTING TREATMENTS TO BE CONDUCTED IN A COMFORTABLE ENVIRONMENT. AS PER THE ERICSSON CONSUMER LAB REPORT (2017), 39% OF PATIENTS SUFFERING FROM CHRONIC DISEASES PREFER ONLINE CONSULTATIONS TO FACE-TO-FACE MEETINGS. MANY HEALTHCARE PROVIDERS ARE ALSO PREFERRING CONNECTED DRUG DELIVERY DEVICES OWING TO BETTER ECONOMIC SENSE TO PERMIT THE TREATMENT OF PATIENTS AT HOME, REDUCED COSTS, ALSO IT FREES UP BEDS AND PRECIOUS TIME OF HEALTHCARE PERSONNEL. CONNECTED DRUG DELIVERY DEVICES HAVE BEEN DEVELOPED FOR THE SUPERVISION AND COUNSELING OF PATIENTS IN A HOME SETTING.

THE DEMAND FOR CONNECTED DRUG DELIVERY DEVICES IS INCREASING ON ACCOUNT OF INCREASING PENETRATION OF THE INTERNET OF THINGS (IOT) IN THE HEALTHCARE DEVICES, INCREASING FOCUS ON PATIENT COMPLIANCE, QUALITY OF HEALTHCARE, RISING AWARENESS OF COSTS, INCREASING USE OF SELF-ADMINISTERED DRUGS, RISING HEALTHCARE PROGRAMS, AND INITIATIVES TO SPREAD THE CONNECTED DRUG DELIVERY DEVICES' AWARENESS. FOR EXAMPLE, PROPELLER HEALTH COMPANY HAS CONDUCTED AROUND 60 CONNECTED MEDICAL PROGRAMS TO SPREAD AWARENESS OF CONNECTED DRUG DELIVERY DEVICES. THE COMPANY PROVIDES ADD-ON DEVICES FOR INHALERS THAT ARE SYNCHRONIZED WITH THE PATIENT'S SOFTWARE FOR THE ANALYSIS OF SYMPTOMS AND DISEASES.

HOWEVER, SOME OF THE RESTRAINTS IN THE MARKET INCLUDE DATA PRIVACY CONCERNS AND ITS HIGH COST.
BASED ON PRODUCTS, THE MARKET IS FRAGMENTED INTO CONNECTED SENSORS AND INTEGRATED CONNECTED DEVICES. THE CONNECTED SENSORS SEGMENT IS EXPECTED TO DOMINATE THE MARKET OWING TO ITS EASY INTEGRATION INSIDE THE ALREADY EXISTING DELIVERY DEVICES WITHOUT ANY INTERRUPTION IN THEIR NORMAL FUNCTIONING. FURTHERMORE, EVEN AFTER THE DISPOSABLE OF EXISTING DELIVERY DEVICES, CONNECTED SENSORS CAN BE REUSED AND INTEGRATED INTO ANOTHER DELIVERY DEVICE. CONNECTED SENSORS ARE FURTHER BIFURCATED INTO CONNECTED INHALER SENSORS AND CONNECTABLE INJECTION SENSORS. THE DEMAND FOR CONNECTED INHALER SENSORS IS INCREASING ON ACCOUNT OF THE HIGH PREVALENCE OF RESPIRATORY DISEASES. SEVERAL RESEARCH COMPANIES ARE WORKING TO CONTROL THE INCIDENCE OF RESPIRATORY DISEASES, FOR INSTANCE, PROPELLER HEALTH IS PROVIDING DIGITAL HEALTH SOLUTIONS FOR RESPIRATORY MEDICINE WITH THE COMBINATION OF ANALYTICS, INHALER DEVICE SENSORS, AND MOBILE APPLICATIONS. PROPELLER HEALTH HAS LAUNCHED SEVERAL CONNECTED INHALER DEVICE SENSORS SUCH AS METERED-DOSE INHALERS (MDIS), DRY POWDER INHALERS (DPI), AND SOFT MIST INHALERS (SMI) FOR THE MONITORING OF COPD AND ASTHMA.

THE INTEGRATED CONNECTED DEVICES ARE EXPECTED TO REGISTER THE FASTEST CAGR IN THE UPCOMING PERIOD. THE INTEGRATED CONNECTED DEVICES SEGMENT IS ALSO SUB-DIVIDED INTO CONNECTED INHALER DEVICES AND CONNECTED INJECTION DEVICES. CONNECTED INHALER DEVICES HOLD SEVERAL BENEFITS OVER THE CONNECTED INJECTION DEVICES BECAUSE OF THE NEEDLELESS DELIVERY OF THE DRUG. THE DEMAND FOR INHALATIONAL DEVICES IN THE MARKET IS INCREASING OWING TO THE HIGH PREVALENCE OF CHRONIC DISEASES SUCH AS CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), AND ASTHMA. AS PER BURDEN OF OBSTRUCTIVE LUNG DISEASE (BOLD), THE GLOBAL PREVALENCE OF COPD IS 10.1%.

BASED ON TECHNOLOGY, THE MARKET IS FRAGMENTED INTO BLUETOOTH, NEAR-FIELD COMMUNICATION (NFC), AND OTHER TECHNOLOGIES. BLUETOOTH SUB-SEGMENT IS EXPECTED TO SHOW SIGNIFICANT GROWTH IN THE FORECAST PERIOD OWING TO ITS HIGH USE IN DRUG DELIVERY DEVICES, AND ITS LOW-COST CONNECTIVITY ACCESS TO SMARTPHONES. THE BLUETOOTH TECHNOLOGY IS EASILY AVAILABLE IN COMPARISON TO NFC AND OTHER TECHNOLOGIES. FOR EXAMPLE, TEVA A PIONEER IN ENHANCING HEALTH AND IMPROVING ACCESS TO QUALITY HEALTHCARE FOR SOCIETY HAS LAUNCHED A BLUETOOTH-ENABLED ALBUTEROL SULFATE RESCUE INHALER. THE NEW INHALER IS AVAILABLE BY PRESCRIPTION TO U.S. PATIENTS AGE 4 AND OLDER, ACCORDING TO THE TEL AVIV, ISRAEL-BASED COMPANY. 'PROAIR DIGIHALER' CONNECTS WITH THE SMARTPHONE TO DETECT AND RECORD COPD AND ASTHMA SYMPTOMS.

BASED ON END-USER, THE MARKET IS DIVIDED INTO HEALTHCARE PROVIDERS, HOMECARE, AND HOSPITALS, AND OTHER END-USERS. THE HOME CARE SEGMENT IS EXPECTED TO REGISTER THE FASTEST CAGR FROM 2021 TO 2028 BECAUSE OF THE RISE IN PRODUCT ACCEPTANCE. THE ADVANTAGE OF USING THESE PRODUCTS IN THE HOMECARE SETTING IS EASY ADMINISTRATION AND WITHOUT THE NEED FOR HEALTHCARE PRACTITIONERS. FURTHERMORE, THE INCREASING INCIDENTS OF CHRONIC DISEASES SUCH AS DIABETES, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), AND CARDIOVASCULAR DISEASES (CVDS) ARE EXPECTED TO FUEL THE HOMECARE SEGMENT GROWTH IN THE FORECAST PERIOD. FOR INSTANCE, AS PER WHO, CARDIOVASCULAR DISEASES (CVDS) ARE THE NUMBER 1 CAUSE OF DEATH GLOBALLY, TAKING AN ESTIMATED 17.9 MILLION LIVES EACH YEAR. FOUR OUT OF 5CVD DEATHS ARE DUE TO HEART ATTACKS AND STROKES, AND ONE-THIRD OF THESE DEATHS OCCUR PREMATURELY IN PEOPLE UNDER 70 YEARS OF AGE.

FOR A BETTER UNDERSTANDING OF THE MARKET ADOPTION OF THE CONNECTED DRUG DELIVERY DEVICES, THE MARKET IS ANALYZED BASED ON ITS WORLDWIDE PRESENCE IN THE COUNTRIES SUCH AS NORTH AMERICA (UNITED STATES, CANADA, AND THE REST OF NORTH AMERICA), EUROPE (GERMANY, FRANCE, ITALY, SPAIN, UNITED KINGDOM AND REST OF EUROPE), ASIA-PACIFIC (CHINA, JAPAN, INDIA, AUSTRALIA, AND REST OF APAC), AND REST OF WORLD. NORTH AMERICA WILL DOMINATE THE CONNECTED DRUG DELIVERY DEVICES MARKET ON ACCOUNT OF THE HIGHLY DEVELOPED HEALTHCARE INFRASTRUCTURE, HEALTHCARE SPENDING, AND PRESENCE OF A LARGE NUMBER OF MARKET PLAYERS IN THE U.S. REGION. FURTHERMORE, EUROPE IS EXPECTED TO BE THE FASTEST-GROWING CONNECTED DRUG DELIVERY DEVICES MARKET OWING TO THE INCREASE IN CHRONIC DISEASES, LARGE PATIENT POPULATION, AND THE RISING PER CAPITA ANIMAL HEALTH EXPENDITURE. FOR INSTANCE, AS PER THE WORLD BANK, THE EUROPEAN UNION HEALTH EXPENDITURE IN 2018 WAS 3,524.71.

SOME OF THE MAJOR PLAYERS OPERATING IN THE MARKET INCLUDE PROPELLER HEALTH (RECIPROCAL LABS CORPORATION), PROTEUS DIGITAL HEALTH, BIOCORP, MERCK KGAA, ADHERIUM LIMITED, WEST PHARMACEUTICAL SERVICES, INC., AMERICA DIGITAL HEALTH, PHILLIPS MIDSIZE, TEVA PHARMACEUTICAL INDUSTRIES LTD, AND FINDAIR. SEVERAL M&AS ALONG WITH PARTNERSHIPS HAVE BEEN UNDERTAKEN BY THESE PLAYERS TO BOOST THEIR PRESENCE IN DIFFERENT REGIONS.

Products


Companies

PROPELLER HEALTH (RECIPROCAL LABS CORPORATION)

PROTEUS DIGITAL HEALTH

BIOCORP

MERCK KGAA

ADHERIUM LIMITED

WEST PHARMACEUTICAL SERVICES

INC.

ATERICA DIGITAL HEALTH

PHILLIPS MEDISIZE

TEVA PHARMACEUTICAL INDUSTRIES LTD AND FINDAIR

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 MARKET DEFINITIONS

1.2 LIMITATION

1.3 STAKE HOLDERS

1.4 CURRENCY USED IN REPORT

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 RESEARCH PROCESS OF THE CONNECTED DRUG DELIVERY DEVICES MARKET

2.2 RESEARCH METHODOLOGY OF THE CONNECTED DRUG DELIVERY DEVICES MARKET

2.3 FORECASTING METHOD

2.4 RESPONDENT PROFILE

2.5 MAIN OBJECTIVE OF THE CONNECTED DRUG DELIVERY DEVICES MARKET STUDY

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET ANALYSIS 2019-27F

6 MARKET INSIGHTS BY PRODUCTS

6.1 INTEGRATED CONNECTED DEVICES

6.1.1 CONNECTED INHALER DEVICES

6.1.2 CONNECTABLE INJECTION DEVICES

6.2 CONNECTED SENSORS

6.2.1 CONNECTED INHALER SENSORS

6.2.2 CONNECTED INJECTION SENSORS

7 MARKET INSIGHTS BY TECHNOLOGY

7.1 BLUETOOTH

7.2 NEAR-FIELD COMMUNICATION (NFC)

7.3 OTHER TECHNOLOGIES

8 MARKET INSIGHTS BY END-USER

8.1 HEALTHCARE PROVIDERS

8.2 HOMECARE

8.3 HOSPITALS

8.4 OTHER END-USERS

9 MARKET INSIGHTS BY REGION

9.1 NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET

9.1.1 UNITED STATES

9.1.2 CANADA

9.1.3 REST OF NORTH AMERICA

9.2 EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET

9.2.1 GERMANY

9.2.2 FRANCE

9.2.3 UNITED KINGDOM

9.2.4 ITALY

9.2.5 SPAIN

9.2.6 REST OF EUROPE

9.3 ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET

9.3.1 CHINA

9.3.2 JAPAN

9.3.3 INDIA

9.3.4 AUSTRALIA

9.3.5 REST OF ASIA PACIFIC

9.4 REST OF WORLD CONNECTED DRUG DELIVERY DEVICES MARKET

10 GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET DYNAMICS

10.1 DRIVERS

10.2 CHALLENGES

10.3 IMPACT ANALYSIS

11 GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET OPPORTUNITIES

12 CONNECTED DRUG DELIVERY DEVICES MARKET TRENDS

13 DEMAND AND SUPPLY SIDE ANALYSIS

13.1 DEMAND SIDE ANALYSIS

13.2 SUPPLY SIDE ANALYSIS

13.2.1 TOP PRODUCT LAUNCHES

13.2.2 TOP BUSINESS PARTNERSHIPS

13.2.3 TOP BUSINESS EXPANSIONS, INVESTMENTS AND DIVESTITURES

13.2.4 TOP MERGER AND ACQUISITIONS

14 VALUE CHAIN ANALYSIS

15 COMPANY PROFILED

15.1 PROPELLER HEALTH (RECIPROCAL LABS CORPORATION)

15.2 PROTEUS DIGITAL HEALTH

15.3 BIOCORP

15.4 MERCK KGAA

15.5 ADHERIUM LIMITED

15.6 WEST PHARMACEUTICAL SERVICES, INC

15.7 ATERICA DIGITAL HEALTH

15.8 PHILLIPS MEDISIZE

15.9 FINDAIR

15.10 TEVA PHARMACEUTICAL INDUSTRIES LTD

16 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022